Related Experiment Video
Updated: Jun 3, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
Unknown primary tumors
C Natoli1, V Ramazzotti, O Nappi
1Unit of Medical Oncology, Department of Oncology and Experimental Medicine and CeSI, Fondazione 'G. D' Annunzio', University of Chieti-Pescara, 66100 Chieti, Italy. natoli@unich.it
Unknown primary tumors (UPTs) present a diagnostic challenge. While molecular techniques and functional imaging show promise, identifying the primary tumor site and improving empirical treatments for UPTs remain critical unmet needs.
Area of Science:
- Oncology
- Diagnostic Medicine
- Molecular Biology
Background:
- Unknown primary tumors (UPTs) are metastatic cancers lacking a clear origin despite diagnostic workup.
- UPTs exhibit rapid progression and symptoms tied to metastatic sites, with their distinct biology unconfirmed.
- Current diagnostic methods, including immunohistochemistry, are time-consuming and often insufficient.
Purpose of the Study:
- To review current diagnostic modalities for unknown primary tumors.
- To highlight advancements in molecular techniques and functional imaging for UPT origin identification.
- To underscore the need for improved treatment strategies for UPTs.
Main Methods:
- Review of immunohistochemistry as a cost-effective diagnostic tool.
- Evaluation of molecular techniques like microarray and miRNA profiling for primary site prediction (up to 90% accuracy).
- Assessment of functional imaging, specifically FDG-PET/CT, in detecting UPT origins.
Main Results:
- Molecular profiling offers high accuracy in predicting primary tumor sites.
- Functional imaging (FDG-PET/CT) is increasingly recommended for UPT diagnosis.
- Despite advancements, the primary tumor site often remains unidentified, complicating treatment.
Conclusions:
- New molecular and imaging techniques enhance the diagnostic capabilities for UPTs.
- Validation of predicted tissue origins and prospective studies on treatment efficacy are lacking.
- Empirical and inadequate treatment remains a significant challenge for UPT patients.
More Related Videos
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...